Organic compositions to treat HSF1-related diseases
The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.
Novartis AG
C Y A A A A C A C C A A C C A A A A A A A C C A
C12N Y02A A61P A61K A61P A61P C12N A61P C12N C12N A61P A61P C12N C12N A61P A61P A61K A61P A61P A61P A61P C12N C07H A61P
additional additional inventional inventional inventional inventional additional inventional inventional additional inventional inventional additional additional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional
Satyanarayana Stuart Ping Tracy S. Wenlai Gregory Jinyun Markus
Kuchimanchi Milstein Zhu Zimmermann Zhou Hinkle Chen Warmuth